Funds from the European Union are not the only source available to the continent's reproductive research community. Each country independently sponsors the work of these scientists, but, as illustrated by snapshots in the following pages, there are huge differences in the commitment of the various European nations to tackle the challenges of reproductive biomedicine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Ethics declarations
Competing interests
H.C. has received peer-reviewed research grant funding from the UK Medical Research Council, the Wellcome Trust, the Chief Scientist Office (Scotland) and Wellbeing of Women.
H.C. has also peer-reviewed research grant funding from organizations not mentioned in the article, including National Health Service Health Technology Assessment Programme, Translational Medicine Research Collaboration (Scotland) and the US National Institutes for Child Health and Development, as well as industry support for laboratory-based studies (Tap Pharmaceuticals and Schering).
Rights and permissions
About this article
Cite this article
Critchley, H., Saunders, P. European funding for reproduction research—A multinational perspective. Nat Med 14, 1224 (2008). https://doi.org/10.1038/nm1108-1224a
Issue date:
DOI: https://doi.org/10.1038/nm1108-1224a
